tetano
Editor, Senior Moderator
Cureus
. 2023 Apr 8;15(4):e37282.
doi: 10.7759/cureus.37282. eCollection 2023 Apr.
Clinical and Laboratory Features of Patients with Multisystem Inflammatory Syndrome in Children (MIS-C): An Experience From Queen Rania Children's Hospital, Jordan
Motasem Alsuwaiti[SUP] 1 [/SUP], Raed Alzyoud[SUP] 1 [/SUP], Hiba Maaitah[SUP] 2 [/SUP], Bushra Aladaileh[SUP] 1 [/SUP], Hamzeh Alnsoor[SUP] 1 [/SUP], Mohammed Nobani[SUP] 1 [/SUP]
Affiliations
Abstract
Background Multisystem inflammatory syndrome in children (MIS-C) is a new clinical observation that emerged during the coronavirus pandemic of 2019 (COVID-19) and has similar manifestations to Kawasaki disease and toxic shock syndrome. In this study, we aim to describe the characteristics of MIS-C patients in a single center in Jordan. Methods A retrospective analysis of electronic medical records of pediatric patients diagnosed with MIS-C at the pediatric rheumatology division of Queen Rania Children's Hospital, Amman, Jordan, between January 2021 and December 2022. Data collected included age, gender, clinical and laboratory data on presentation, and treatment options, which were compared in two different age groups. Results A total of 80 patients were included in this cohort (53 males and 27 females). The mean age at presentation was 84.4 months (ranging between nine months and 16 years). The most common presenting symptoms included fever (100%), abdominal pain (76.2%), skin rash (75%), conjunctivitis (72.5%), and mucosal changes (62.5%). Lymphopenia was present in 66.2% of patients. The majority of patients (98.7%) showed elevated C-reactive protein (CRP); 72 patients showed elevated erythrocyte sedimentation rate (ESR) (92.5%); ferritin was elevated in 70% of patients; the median fibrinogen level was 390 (interquartile range (IQR) 0.6-20) mg/dL; and the D-dimer level was 3.9 (IQR 0.6-20) mg/dL. Pericardial effusion was present in 23.8% of patients, and five patients (6.3%) had coronary artery dilatation. Conclusion To the best of our knowledge, this study is the first large case series of MIS-C in Jordan, with a wide spectrum of clinical presentation and evidence of hyperinflammation.
Keywords: covid-19; hyperinflammation; jordan; mis-c; mis-c in children; multi-system inflammatory syndrome in children (mis-c); multisystem inflammatory syndrome in children.
. 2023 Apr 8;15(4):e37282.
doi: 10.7759/cureus.37282. eCollection 2023 Apr.
Clinical and Laboratory Features of Patients with Multisystem Inflammatory Syndrome in Children (MIS-C): An Experience From Queen Rania Children's Hospital, Jordan
Motasem Alsuwaiti[SUP] 1 [/SUP], Raed Alzyoud[SUP] 1 [/SUP], Hiba Maaitah[SUP] 2 [/SUP], Bushra Aladaileh[SUP] 1 [/SUP], Hamzeh Alnsoor[SUP] 1 [/SUP], Mohammed Nobani[SUP] 1 [/SUP]
Affiliations
- PMID: 37038378
- PMCID: PMC10082549
- DOI: 10.7759/cureus.37282
Abstract
Background Multisystem inflammatory syndrome in children (MIS-C) is a new clinical observation that emerged during the coronavirus pandemic of 2019 (COVID-19) and has similar manifestations to Kawasaki disease and toxic shock syndrome. In this study, we aim to describe the characteristics of MIS-C patients in a single center in Jordan. Methods A retrospective analysis of electronic medical records of pediatric patients diagnosed with MIS-C at the pediatric rheumatology division of Queen Rania Children's Hospital, Amman, Jordan, between January 2021 and December 2022. Data collected included age, gender, clinical and laboratory data on presentation, and treatment options, which were compared in two different age groups. Results A total of 80 patients were included in this cohort (53 males and 27 females). The mean age at presentation was 84.4 months (ranging between nine months and 16 years). The most common presenting symptoms included fever (100%), abdominal pain (76.2%), skin rash (75%), conjunctivitis (72.5%), and mucosal changes (62.5%). Lymphopenia was present in 66.2% of patients. The majority of patients (98.7%) showed elevated C-reactive protein (CRP); 72 patients showed elevated erythrocyte sedimentation rate (ESR) (92.5%); ferritin was elevated in 70% of patients; the median fibrinogen level was 390 (interquartile range (IQR) 0.6-20) mg/dL; and the D-dimer level was 3.9 (IQR 0.6-20) mg/dL. Pericardial effusion was present in 23.8% of patients, and five patients (6.3%) had coronary artery dilatation. Conclusion To the best of our knowledge, this study is the first large case series of MIS-C in Jordan, with a wide spectrum of clinical presentation and evidence of hyperinflammation.
Keywords: covid-19; hyperinflammation; jordan; mis-c; mis-c in children; multi-system inflammatory syndrome in children (mis-c); multisystem inflammatory syndrome in children.